Your browser doesn't support javascript.
loading
Clinical Evaluation of the Accuracy of the Panbio™ COVID-19/Flu A&B Rapid Panel: A Combination Antigen Rapid Diagnostic Test for the Omicron Variant and Influenza A Virus.
Yamagishi, Hirokazu; Tamura, Daisuke; Yamazaki, Masahiko; Abe, Takashi; Mitamura, Keiko; Tajima, Toshihiro; Osaka, Hitoshi.
Afiliación
  • Yamagishi H; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
  • Tamura D; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
  • Yamazaki M; Department of Pediatrics, Zama Children's Clinic, Zama, Japan.
  • Abe T; Department of Pediatrics, Abe Children's Clinic, Yokohama, Japan.
  • Mitamura K; Department of Pediatrics, Eiju General Hospital, Tokyo, Japan.
  • Tajima T; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
  • Osaka H; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Viral Immunol ; 37(6): 317-321, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39001845
ABSTRACT
It is difficult to differentiate between coronavirus disease 2019 (COVID-19) and influenza based on the symptoms. In the present study, a newly developed antigen rapid diagnostic test (Ag-RDT) called Panbio™ COVID-19/Flu A&B that can simultaneously detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A/B virus was evaluated. Its accuracy was evaluated using 235 pairs of nasopharyngeal samples collected from patients with respiratory symptoms and fever (>37.5°C). Reverse transcription polymerase chain reaction was used as a reference method to evaluate the accuracy of the SARS-CoV-2 detection. We confirmed the accuracy of the developed Ag-RDT against the Omicron variant where the sensitivity and specificity were 94.8% and 100%, respectively. In addition, to identify the influenza A virus, a noninferiority test was conducted using a commercial Ag-RDT, which has a sensitivity and specificity in comparison with viral culture of 94.8% and 98.4%, respectively. The positive and negative predictive values for influenza A virus were 98.5% and 98.1%, respectively, for the Panbio COVID-19/Flu A&B test. The evaluation of this newly developed Ag-RDT using clinical samples suggests that it has a high efficacy in clinical settings.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus de la Influenza A / Virus de la Influenza B / Gripe Humana / SARS-CoV-2 / COVID-19 / Prueba de Diagnóstico Rápido / Antígenos Virales Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn Idioma: En Revista: Viral Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / VIROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus de la Influenza A / Virus de la Influenza B / Gripe Humana / SARS-CoV-2 / COVID-19 / Prueba de Diagnóstico Rápido / Antígenos Virales Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn Idioma: En Revista: Viral Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / VIROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos